P&G Ventures Archives - CDR – Chain Drug Review

P&G’s Opte Precision Skincare returns to CES 2020

January 3, 2020 by Chain Drug Review at-home precise skincare solutions, beauty, CES 2020, Opte Precision Skincare System, P&G Ventures Supplier News

LAS VEGAS — P&G Ventures, the startup studio within Procter & Gamble, has returned to CES 2020 to showcase the development of the Opte Precision Skincare System, the first personalized handheld inkjet printer that is said to instantly make the appearance of skin’s hyperpigmentation disappear and fade spots over time. Bringing smart technology to beauty,

P&G Ventures to showcase the Opté Precision Skincare System at CES

January 4, 2019 by Chain Drug Review Leigh Radford, Opté Precision Skincare System (Opté), Opté Precision Wand, P&G Ventures Supplier News, Technology

LAS VEGAS — P&G Ventures, the startup studio within Procter & Gamble, today unveiled Opté Precision Skincare System (Opté) at CES 2019. After years of development and over 40 patents, Opté has combined the best of optics, proprietary algorithms, printing technology, and skincare in one device. Opté scans, detects, and corrects hyperpigmentation with precision application to reveal